-

FTC Obtains Permanent Ban and $2M Judgment for Work-From-Home Scammer Falsely Using Amazon Name

SEATTLE--(BUSINESS WIRE)--Amazon.com, Inc. (NASDAQ: AMZN):

What:

On Friday, March 12, the U.S. District Court of Utah entered the Federal Trade Commission’s filed order against Randon Morris and four companies he controls for operating a telemarketing scheme that fraudulently used Amazon Associates name. The defendants leveraged pandemic fears to offer fake work-from-home opportunities, falsely representing Amazon’s Associates Program. The defendants are prevented from ever selling similar services in the future and will be responsible for a more than $2 million settlement.

You can read the FTC’s press release on the case here.

Statement from Amazon:

Amazon works hard to delight our customers, and we appreciate the Federal Trade Commission’s thorough pursuit of these criminals who deceptively used our name to dupe customers. We will continue to work with the Federal Trade Commission and other law enforcement organizations to stop these scams and protect customers.

Amazon has an extensive history of protecting its customers from fraud and abuse:

 

Contacts

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

Industry:

Amazon.com, Inc.

NASDAQ:AMZN
Release Summary
FTC Obtains Permanent Ban and $2M Judgment for Work-From-Home Scammer Falsely Using Amazon Name
Release Versions
English

Contacts

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

More News From Amazon.com, Inc.

Amazon Pharmacy Expands Access to Eli Lilly’s Zepbound KwikPen for Weight Management

SEATTLE--(BUSINESS WIRE)--Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications quickly and directly to customers' homes, today announced expanded access to the new Zepbound® KwikPen® through Amazon Pharmacy. Eli Lilly's multi-dose injectable treatment for weight management is designed to deliver a full month of medication in a single device, offering patients a more convenient alternative by reducing the number of single-dose devices required. With a valid p...

OpenAI and Amazon Announce Strategic Partnership

SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)--OpenAI and Amazon (NASDAQ: AMZN) today announced a multi-year strategic partnership to accelerate AI innovation for enterprises, startups, and end consumers around the world. Amazon will also invest $50 billion in OpenAI, starting with an initial $15 billion investment and followed by another $35 billion in the coming months when certain conditions are met. Partnering to bring new advanced AI capabilities to enterprises worldwide OpenAI and Amazon are j...

Amazon Pharmacy Will Expand Same-Day Medication Delivery to Nearly 4,500 U.S. Cities and Towns by Year End

SEATTLE--(BUSINESS WIRE)--Amazon Pharmacy today announced it will expand its Same-Day prescription delivery service to nearly 4,500 U.S. cities and towns by the end of 2026—adding nearly 2,000 new communities over the course of the year. The expansion will bring fast, reliable medication delivery to millions of customers nationwide, including new states such as Idaho and Massachusetts, where pharmacy closures, staffing shortages, and transportation barriers have historically limited access to c...
Back to Newsroom